Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 0.65 | 0.60 | 0.48 | 0.25 |
Depreciation/ Depletion | 0.13 | 0.13 | 0.20 | 0.19 |
Non- Cash Items | -0.24 | -0.10 | -0.10 | -0.08 |
Changesin Working Capital | 0.49 | -0.23 | -0.12 | 1.80 |
Cashfrom Operating Activities | 1.03 | 0.40 | 0.47 | 2.16 |
Other Investing Cash Flow Items Total | 0.01 | 0.01 | 0.01 | 0.00 |
Cashfrom Investing Activities | 0.01 | 0.01 | -0.03 | -0.15 |
Financing Cash Flow Items | 0.23 | 0.11 | 0.09 | 0.08 |
Cashfrom Financing Activities | 0.23 | 0.11 | 0.09 | 0.08 |
Net Changein Cash | 1.27 | 0.52 | 0.52 | 2.08 |
Cash Interest Paid | 0.04 | 0.05 | 0.08 | 0.09 |
Cash Taxes Paid | 0.18 | 0.16 | 0.15 | 0.08 |
Capital Expenditures | - | 0.00 | -0.04 | -0.16 |
Colinz Laboratories Dividend Colinz Laboratories Bonus Colinz Laboratories News Colinz Laboratories AGM Colinz Laboratories Rights Colinz Laboratories Splits Colinz Laboratories Board Meetings Colinz Laboratories Key Metrics Colinz Laboratories Shareholdings Colinz Laboratories Profit Loss Colinz Laboratories Balance Sheet Colinz Laboratories Q1 Results Colinz Laboratories Q2 Results Colinz Laboratories Q3 Results Colinz Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks